Company profile
CEL SCI CORP
AMEX:CVMBiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01265849 | phase3 | completed | 2010-12-01 | 2020-05-15 | CEL-SCI Corporation | Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity |
| NCT03038828 | phase1 | terminated | 2015-04-01 | 2018-06-01 | CEL-SCI Corporation | Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts |
FDA applications (0)
No records yet.